Acute myeloid leukemia, version 3.2019

Martin S. Tallman, Eunice S. Wang, Jessica K. Altman, Frederick R. Appelbaum, Vijaya Raj Bhatt, Dale Bixby, Steven E. Coutre, Marcos De Lima, Amir T. Fathi, Melanie Fiorella, James M. Foran, Aric C. Hall, Meagan Jacoby, Jeffrey Lancet, Thomas W. LeBlanc, Gabriel Mannis, Guido Marcucci, Michael G. Martin, Alice Mims, Margaret R. O'DonnellRebecca Olin, Deniz Peker, Alexander Perl, Daniel A. Pollyea, Keith Pratz, Thomas Prebet, Farhad Ravandi, Paul J. Shami, Richard M. Stone, Stephen A. Strickland, Matthew Wieduwilt, Kristina M. Gregory, Lydia Hammond, Ndiya Ogba

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

Original languageEnglish (US)
Pages (from-to)721-749
Number of pages29
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume17
Issue number6
DOIs
StatePublished - Jan 1 2019

Fingerprint

Acute Myeloid Leukemia
Leukemia
Practice Guidelines
Therapeutics
Guidelines

ASJC Scopus subject areas

  • Oncology

Cite this

Tallman, M. S., Wang, E. S., Altman, J. K., Appelbaum, F. R., Bhatt, V. R., Bixby, D., ... Ogba, N. (2019). Acute myeloid leukemia, version 3.2019. JNCCN Journal of the National Comprehensive Cancer Network, 17(6), 721-749. https://doi.org/10.6004/jnccn.2019.0028

Acute myeloid leukemia, version 3.2019. / Tallman, Martin S.; Wang, Eunice S.; Altman, Jessica K.; Appelbaum, Frederick R.; Bhatt, Vijaya Raj; Bixby, Dale; Coutre, Steven E.; De Lima, Marcos; Fathi, Amir T.; Fiorella, Melanie; Foran, James M.; Hall, Aric C.; Jacoby, Meagan; Lancet, Jeffrey; LeBlanc, Thomas W.; Mannis, Gabriel; Marcucci, Guido; Martin, Michael G.; Mims, Alice; O'Donnell, Margaret R.; Olin, Rebecca; Peker, Deniz; Perl, Alexander; Pollyea, Daniel A.; Pratz, Keith; Prebet, Thomas; Ravandi, Farhad; Shami, Paul J.; Stone, Richard M.; Strickland, Stephen A.; Wieduwilt, Matthew; Gregory, Kristina M.; Hammond, Lydia; Ogba, Ndiya.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 17, No. 6, 01.01.2019, p. 721-749.

Research output: Contribution to journalArticle

Tallman, MS, Wang, ES, Altman, JK, Appelbaum, FR, Bhatt, VR, Bixby, D, Coutre, SE, De Lima, M, Fathi, AT, Fiorella, M, Foran, JM, Hall, AC, Jacoby, M, Lancet, J, LeBlanc, TW, Mannis, G, Marcucci, G, Martin, MG, Mims, A, O'Donnell, MR, Olin, R, Peker, D, Perl, A, Pollyea, DA, Pratz, K, Prebet, T, Ravandi, F, Shami, PJ, Stone, RM, Strickland, SA, Wieduwilt, M, Gregory, KM, Hammond, L & Ogba, N 2019, 'Acute myeloid leukemia, version 3.2019', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, no. 6, pp. 721-749. https://doi.org/10.6004/jnccn.2019.0028
Tallman MS, Wang ES, Altman JK, Appelbaum FR, Bhatt VR, Bixby D et al. Acute myeloid leukemia, version 3.2019. JNCCN Journal of the National Comprehensive Cancer Network. 2019 Jan 1;17(6):721-749. https://doi.org/10.6004/jnccn.2019.0028
Tallman, Martin S. ; Wang, Eunice S. ; Altman, Jessica K. ; Appelbaum, Frederick R. ; Bhatt, Vijaya Raj ; Bixby, Dale ; Coutre, Steven E. ; De Lima, Marcos ; Fathi, Amir T. ; Fiorella, Melanie ; Foran, James M. ; Hall, Aric C. ; Jacoby, Meagan ; Lancet, Jeffrey ; LeBlanc, Thomas W. ; Mannis, Gabriel ; Marcucci, Guido ; Martin, Michael G. ; Mims, Alice ; O'Donnell, Margaret R. ; Olin, Rebecca ; Peker, Deniz ; Perl, Alexander ; Pollyea, Daniel A. ; Pratz, Keith ; Prebet, Thomas ; Ravandi, Farhad ; Shami, Paul J. ; Stone, Richard M. ; Strickland, Stephen A. ; Wieduwilt, Matthew ; Gregory, Kristina M. ; Hammond, Lydia ; Ogba, Ndiya. / Acute myeloid leukemia, version 3.2019. In: JNCCN Journal of the National Comprehensive Cancer Network. 2019 ; Vol. 17, No. 6. pp. 721-749.
@article{08a9fd81ea7243c4b961eb28a0d841b1,
title = "Acute myeloid leukemia, version 3.2019",
abstract = "Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.",
author = "Tallman, {Martin S.} and Wang, {Eunice S.} and Altman, {Jessica K.} and Appelbaum, {Frederick R.} and Bhatt, {Vijaya Raj} and Dale Bixby and Coutre, {Steven E.} and {De Lima}, Marcos and Fathi, {Amir T.} and Melanie Fiorella and Foran, {James M.} and Hall, {Aric C.} and Meagan Jacoby and Jeffrey Lancet and LeBlanc, {Thomas W.} and Gabriel Mannis and Guido Marcucci and Martin, {Michael G.} and Alice Mims and O'Donnell, {Margaret R.} and Rebecca Olin and Deniz Peker and Alexander Perl and Pollyea, {Daniel A.} and Keith Pratz and Thomas Prebet and Farhad Ravandi and Shami, {Paul J.} and Stone, {Richard M.} and Strickland, {Stephen A.} and Matthew Wieduwilt and Gregory, {Kristina M.} and Lydia Hammond and Ndiya Ogba",
year = "2019",
month = "1",
day = "1",
doi = "10.6004/jnccn.2019.0028",
language = "English (US)",
volume = "17",
pages = "721--749",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "6",

}

TY - JOUR

T1 - Acute myeloid leukemia, version 3.2019

AU - Tallman, Martin S.

AU - Wang, Eunice S.

AU - Altman, Jessica K.

AU - Appelbaum, Frederick R.

AU - Bhatt, Vijaya Raj

AU - Bixby, Dale

AU - Coutre, Steven E.

AU - De Lima, Marcos

AU - Fathi, Amir T.

AU - Fiorella, Melanie

AU - Foran, James M.

AU - Hall, Aric C.

AU - Jacoby, Meagan

AU - Lancet, Jeffrey

AU - LeBlanc, Thomas W.

AU - Mannis, Gabriel

AU - Marcucci, Guido

AU - Martin, Michael G.

AU - Mims, Alice

AU - O'Donnell, Margaret R.

AU - Olin, Rebecca

AU - Peker, Deniz

AU - Perl, Alexander

AU - Pollyea, Daniel A.

AU - Pratz, Keith

AU - Prebet, Thomas

AU - Ravandi, Farhad

AU - Shami, Paul J.

AU - Stone, Richard M.

AU - Strickland, Stephen A.

AU - Wieduwilt, Matthew

AU - Gregory, Kristina M.

AU - Hammond, Lydia

AU - Ogba, Ndiya

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

AB - Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients.

UR - http://www.scopus.com/inward/record.url?scp=85068181660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068181660&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2019.0028

DO - 10.6004/jnccn.2019.0028

M3 - Article

C2 - 31200351

AN - SCOPUS:85068181660

VL - 17

SP - 721

EP - 749

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 6

ER -